Others are faster growing ('aggressive'), for example, diffuse large B-cell lymphoma, Burkitt’s lymphoma and mantle cell lymphoma. Roche’s heritage in non-hodgkin lymphoma treatment Rituximab ...

T-cell skin lymphomas are more common than B-cell skin lymphomas. Cutaneous T-cell lymphoma (CTCL) occurs when a mutation causes the cell to divide too quickly and stay alive too long. The ...

Both ultraviolet A (UVA) and ultraviolet B (UVB) light have documented efficacy for treating MF (Abe, Ohnishi, Kan, & Ishikawa, 2003; Herrmann et al., 1995; Querfeld et al., 2005) and response is ...

Innate Pharma has gained breakthrough therapy designation for lacutamab to treat adults with relapsed or refractory Sézary ...

Figure 1: FoxP3 immunoperoxidase stain (brown) of regulatory T cells in cutaneous T-cell lymphoma. Note the smaller nuclei of FoxP3 + cells compared with tumor cells (arrows). Full size image ...

Matthew S. McKinney, MD, reflects on his first experience of treating a patient with diffuse large B-cell lymphoma (DLBCL) as a new attending at Duke University. The patient, a woman with multiple ...

My research is aimed at developing an improved understanding of new therapies for patients with several less-common types of lymphoma, including T cell lymphomas, cutaneous (skin) lymphomas, Hodgkin ...